Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); PTO Review; No Fundamental Change to AMR101 Opportunity
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Price: $14.09 +0.21%
Rating Summary:
6 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
6 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $35.00.
Canaccord analyst, Ritu Baral, says, "Reiterate rating and price target on commercial, partnership potential of AMR101. AMR101 is AMRN’s 96% EPA omega-3 drug for very high triglycerides (TG). AMRN plans to submit the AMR101 NDA for high TG in Q3/11. We think AMR101 will be approved mid-2012. We expect significant progress in IP and business development in H2/12."
"After reviewing the PTO examiner’s responses to AMRN’s counterarguments in the June non-final rejection, we think future discussion with the PTO will focus on non-obviousness and surprising findings based on a person with ordinary skill in the art. We think additional responses and office actions may extend into H1/12."
For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.
Shares of Amarin Corporation closed at $10.10 yesterday.
Canaccord analyst, Ritu Baral, says, "Reiterate rating and price target on commercial, partnership potential of AMR101. AMR101 is AMRN’s 96% EPA omega-3 drug for very high triglycerides (TG). AMRN plans to submit the AMR101 NDA for high TG in Q3/11. We think AMR101 will be approved mid-2012. We expect significant progress in IP and business development in H2/12."
"After reviewing the PTO examiner’s responses to AMRN’s counterarguments in the June non-final rejection, we think future discussion with the PTO will focus on non-obviousness and surprising findings based on a person with ordinary skill in the art. We think additional responses and office actions may extend into H1/12."
For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.
Shares of Amarin Corporation closed at $10.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
- Kotak Upgrades Narayana Hrudayalaya Ltd (NARH:IN) to Buy (1)
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
